nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—AK2—Synthesis and interconversion of nucleotide di- and triphosphates—GSR—amyotrophic lateral sclerosis	0.0603	0.143	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Synthesis and interconversion of nucleotide di- and triphosphates—GSR—amyotrophic lateral sclerosis	0.0418	0.0992	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Synthesis and interconversion of nucleotide di- and triphosphates—GSR—amyotrophic lateral sclerosis	0.0317	0.0752	CbGpPWpGaD
Adefovir Dipivoxil—NME2—hindbrain—amyotrophic lateral sclerosis	0.0278	0.105	CbGeAlD
Adefovir Dipivoxil—SLC22A3—Synaptic Vesicle Pathway—UNC13A—amyotrophic lateral sclerosis	0.0205	0.0487	CbGpPWpGaD
Adefovir Dipivoxil—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0195	0.0623	CcSEcCtD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.0187	0.0443	CbGpPWpGaD
Adefovir Dipivoxil—NME2—embryo—amyotrophic lateral sclerosis	0.0174	0.0654	CbGeAlD
Adefovir Dipivoxil—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0551	CcSEcCtD
Adefovir Dipivoxil—NME2—brainstem—amyotrophic lateral sclerosis	0.0159	0.06	CbGeAlD
Adefovir Dipivoxil—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0505	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—tongue—amyotrophic lateral sclerosis	0.015	0.0567	CbGeAlD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—RAB5A—amyotrophic lateral sclerosis	0.014	0.0331	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0419	CcSEcCtD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.0129	0.0307	CbGpPWpGaD
Adefovir Dipivoxil—AK4—medulla oblongata—amyotrophic lateral sclerosis	0.0114	0.0428	CbGeAlD
Adefovir Dipivoxil—AK2—cerebellum—amyotrophic lateral sclerosis	0.0109	0.0409	CbGeAlD
Adefovir Dipivoxil—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0338	CcSEcCtD
Adefovir Dipivoxil—AK4—spinal cord—amyotrophic lateral sclerosis	0.0101	0.0381	CbGeAlD
Adefovir Dipivoxil—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0323	CcSEcCtD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.0098	0.0233	CbGpPWpGaD
Adefovir Dipivoxil—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00971	0.031	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00896	0.0286	CcSEcCtD
Adefovir Dipivoxil—NME1—nervous system—amyotrophic lateral sclerosis	0.00885	0.0333	CbGeAlD
Adefovir Dipivoxil—AK2—brain—amyotrophic lateral sclerosis	0.00882	0.0332	CbGeAlD
Adefovir Dipivoxil—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00861	0.0275	CcSEcCtD
Adefovir Dipivoxil—AK4—nervous system—amyotrophic lateral sclerosis	0.00853	0.0321	CbGeAlD
Adefovir Dipivoxil—NME1—central nervous system—amyotrophic lateral sclerosis	0.00852	0.0321	CbGeAlD
Adefovir Dipivoxil—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00842	0.0269	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00835	0.0267	CcSEcCtD
Adefovir Dipivoxil—NME2—nervous system—amyotrophic lateral sclerosis	0.00834	0.0314	CbGeAlD
Adefovir Dipivoxil—NME1—cerebellum—amyotrophic lateral sclerosis	0.00833	0.0314	CbGeAlD
Adefovir Dipivoxil—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00829	0.0265	CcSEcCtD
Adefovir Dipivoxil—AK4—central nervous system—amyotrophic lateral sclerosis	0.00822	0.0309	CbGeAlD
Adefovir Dipivoxil—AK4—cerebellum—amyotrophic lateral sclerosis	0.00803	0.0302	CbGeAlD
Adefovir Dipivoxil—NME2—central nervous system—amyotrophic lateral sclerosis	0.00803	0.0302	CbGeAlD
Adefovir Dipivoxil—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00793	0.0253	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00787	0.0251	CcSEcCtD
Adefovir Dipivoxil—NME2—cerebellum—amyotrophic lateral sclerosis	0.00785	0.0296	CbGeAlD
Adefovir Dipivoxil—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00783	0.025	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00779	0.0249	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00777	0.0248	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—embryo—amyotrophic lateral sclerosis	0.00721	0.0272	CbGeAlD
Adefovir Dipivoxil—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0069	0.0221	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0068	0.0217	CcSEcCtD
Adefovir Dipivoxil—NME1—brain—amyotrophic lateral sclerosis	0.00677	0.0255	CbGeAlD
Adefovir Dipivoxil—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00668	0.0213	CcSEcCtD
Adefovir Dipivoxil—AK4—brain—amyotrophic lateral sclerosis	0.00652	0.0246	CbGeAlD
Adefovir Dipivoxil—ABCC5—medulla oblongata—amyotrophic lateral sclerosis	0.00645	0.0243	CbGeAlD
Adefovir Dipivoxil—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00638	0.0204	CcSEcCtD
Adefovir Dipivoxil—NME2—brain—amyotrophic lateral sclerosis	0.00637	0.024	CbGeAlD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—amyotrophic lateral sclerosis	0.00614	0.0146	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.0061	0.0145	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Riluzole—amyotrophic lateral sclerosis	0.00602	0.0192	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00588	0.0188	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00588	0.0188	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00584	0.0187	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00553	0.0177	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00552	0.0176	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00547	0.0175	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00537	0.0172	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00513	0.0164	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00497	0.0118	CbGpPWpGaD
Adefovir Dipivoxil—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00496	0.0158	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Synaptic Vesicle Pathway—SLC1A3—amyotrophic lateral sclerosis	0.0049	0.0116	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0049	0.0156	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00486	0.0155	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00461	0.0147	CcSEcCtD
Adefovir Dipivoxil—ABCC5—cerebellum—amyotrophic lateral sclerosis	0.00456	0.0172	CbGeAlD
Adefovir Dipivoxil—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00445	0.0142	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00445	0.0142	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—brain—amyotrophic lateral sclerosis	0.00425	0.016	CbGeAlD
Adefovir Dipivoxil—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00404	0.0129	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00399	0.0127	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00386	0.0123	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.00374	0.00886	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—brain—amyotrophic lateral sclerosis	0.0037	0.0139	CbGeAlD
Adefovir Dipivoxil—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00358	0.0114	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.00356	0.00844	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Riluzole—amyotrophic lateral sclerosis	0.00355	0.0114	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00355	0.0113	CcSEcCtD
Adefovir Dipivoxil—Headache—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0113	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.00346	0.013	CbGeAlD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00342	0.00812	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.00336	0.00798	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—nervous system—amyotrophic lateral sclerosis	0.00336	0.0126	CbGeAlD
Adefovir Dipivoxil—AK2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00335	0.00795	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00335	0.00795	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00335	0.0107	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.00333	0.0126	CbGeAlD
Adefovir Dipivoxil—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.00333	0.0125	CbGeAlD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00332	0.00787	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.00323	0.0122	CbGeAlD
Adefovir Dipivoxil—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.00321	0.0121	CbGeAlD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00321	0.00761	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.0032	0.0076	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00312	0.00741	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—amyotrophic lateral sclerosis	0.00307	0.00728	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00307	0.00727	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00285	0.00676	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00268	0.00636	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—brain—amyotrophic lateral sclerosis	0.00265	0.00997	CbGeAlD
Adefovir Dipivoxil—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00261	0.00619	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MMP9—amyotrophic lateral sclerosis	0.00257	0.00609	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—brain—amyotrophic lateral sclerosis	0.00257	0.00967	CbGeAlD
Adefovir Dipivoxil—SLC22A8—brain—amyotrophic lateral sclerosis	0.00255	0.00959	CbGeAlD
Adefovir Dipivoxil—AK2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00242	0.00575	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00241	0.00573	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00235	0.00558	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00235	0.00557	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00232	0.00551	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00232	0.00551	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00222	0.00527	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00213	0.00504	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00203	0.00483	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00198	0.00469	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00196	0.00466	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MMP9—amyotrophic lateral sclerosis	0.00195	0.00462	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00194	0.00461	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00186	0.00441	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00184	0.00436	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00181	0.00429	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00176	0.00418	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00176	0.00418	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TP53—amyotrophic lateral sclerosis	0.00174	0.00413	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GSR—amyotrophic lateral sclerosis	0.0017	0.00402	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00168	0.00399	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.00166	0.00393	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00163	0.00386	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.00163	0.00386	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00161	0.00382	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00157	0.00371	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.00155	0.00367	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00154	0.00365	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0015	0.00355	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.00149	0.00354	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.00143	0.0034	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00141	0.00336	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00141	0.00335	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00141	0.00334	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00139	0.0033	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00133	0.00316	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TP53—amyotrophic lateral sclerosis	0.00132	0.00313	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00132	0.00313	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00127	0.00302	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00127	0.00302	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00125	0.00297	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00123	0.00293	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00123	0.00292	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.0012	0.00285	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00119	0.00281	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00118	0.00279	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00118	0.00279	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TPK1—amyotrophic lateral sclerosis	0.00114	0.00269	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00111	0.00264	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.00109	0.0026	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00107	0.00254	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00107	0.00253	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00102	0.00241	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.001	0.00238	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000994	0.00236	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000992	0.00235	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000991	0.00235	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000981	0.00233	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000965	0.00229	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000965	0.00229	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000951	0.00226	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000951	0.00226	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000945	0.00224	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000929	0.0022	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—VTA1—amyotrophic lateral sclerosis	0.000908	0.00215	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000892	0.00212	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00089	0.00211	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00087	0.00206	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000862	0.00205	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000854	0.00203	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000843	0.002	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000843	0.002	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000809	0.00192	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000795	0.00189	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000794	0.00188	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000769	0.00182	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000763	0.00181	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000763	0.00181	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00076	0.0018	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000751	0.00178	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000748	0.00177	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000731	0.00173	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000721	0.00171	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000717	0.0017	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000698	0.00165	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000688	0.00163	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000688	0.00163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000688	0.00163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000687	0.00163	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000676	0.0016	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000676	0.0016	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000652	0.00155	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000649	0.00154	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000648	0.00154	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000647	0.00153	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PLB1—amyotrophic lateral sclerosis	0.000622	0.00148	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000617	0.00146	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00061	0.00145	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00061	0.00145	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00061	0.00145	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000603	0.00143	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000598	0.00142	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000584	0.00139	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000584	0.00139	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000566	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—VCP—amyotrophic lateral sclerosis	0.000555	0.00132	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000551	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000543	0.00129	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000521	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000521	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000519	0.00123	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000509	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000509	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000481	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000477	0.00113	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000453	0.00108	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.00044	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000418	0.000991	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CST3—amyotrophic lateral sclerosis	0.000398	0.000944	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000395	0.000937	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000393	0.000932	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000392	0.00093	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000388	0.00092	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000386	0.000915	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000372	0.000882	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000361	0.000857	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000333	0.000791	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000317	0.000751	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000297	0.000705	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CASP9—amyotrophic lateral sclerosis	0.000289	0.000687	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000287	0.000681	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000269	0.000637	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB4—amyotrophic lateral sclerosis	0.000248	0.000588	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000227	0.000538	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000212	0.000503	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000204	0.000483	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000195	0.000463	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—APOE—amyotrophic lateral sclerosis	0.000192	0.000455	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00017	0.000404	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—APOE—amyotrophic lateral sclerosis	0.00016	0.000381	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000156	0.000371	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000148	0.000351	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTGS2—amyotrophic lateral sclerosis	0.000131	0.000311	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	0.000129	0.000305	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000112	0.000265	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.00011	0.000261	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.82e-05	0.000209	CbGpPWpGaD
